These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 6173312

  • 21. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
    Mosser DM, Edelson PJ.
    J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545
    [Abstract] [Full Text] [Related]

  • 22. Effect of cetylmannoside modification on the alternative complement pathway activation by liposomes in rat serum.
    Matsuo H, Yamashita C, Akiyama K, Kiwada H.
    Biol Pharm Bull; 1995 Apr; 18(4):581-5. PubMed ID: 7655432
    [Abstract] [Full Text] [Related]

  • 23. Effect of serum components from different species on destabilizing hydrogenated phosphatidylcholine-based liposomes.
    Liu S, Ishida T, Kiwada H.
    Biol Pharm Bull; 1997 Aug; 20(8):874-80. PubMed ID: 9300134
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids.
    Bradley AJ, Devine DV, Ansell SM, Janzen J, Brooks DE.
    Arch Biochem Biophys; 1998 Sep 15; 357(2):185-94. PubMed ID: 9735159
    [Abstract] [Full Text] [Related]

  • 25. Prevention of complement activation on the homologous cell membrane of nucleated cells as well as erythrocytes.
    Okada H, Tanaka H, Okada N.
    Eur J Immunol; 1983 Apr 15; 13(4):340-4. PubMed ID: 6221932
    [Abstract] [Full Text] [Related]

  • 26. Cholesterol-dependent human complement activation resulting in damage to liposomal model membranes.
    Alving CR, Richards RL, Guirguis AA.
    J Immunol; 1977 Jan 15; 118(1):342-7. PubMed ID: 830757
    [Abstract] [Full Text] [Related]

  • 27. Effect of liposomal model membrane composition on immunogenicity.
    Dancey GF, Yasuda T, Kinsky SC.
    J Immunol; 1978 Apr 15; 120(4):1109-13. PubMed ID: 641340
    [Abstract] [Full Text] [Related]

  • 28. Plasma factor triggering alternative complement pathway activation by liposomes.
    Funato K, Yamashita C, Kamada J, Tominaga S, Kiwada H.
    Pharm Res; 1994 Mar 15; 11(3):372-6. PubMed ID: 8008701
    [Abstract] [Full Text] [Related]

  • 29. Complement activation in rats by liposomes and liposome-encapsulated hemoglobin: evidence for anti-lipid antibodies and alternative pathway activation.
    Szebeni J, Wassef NM, Spielberg H, Rudolph AS, Alving CR.
    Biochem Biophys Res Commun; 1994 Nov 30; 205(1):255-63. PubMed ID: 7999033
    [Abstract] [Full Text] [Related]

  • 30. Specific targeting of phototoxic haptenated liposomes to a hapten-specific B cell lymphoma.
    Avrilionis K, Boggs JM.
    Cell Immunol; 1996 Feb 25; 168(1):13-23. PubMed ID: 8599835
    [Abstract] [Full Text] [Related]

  • 31. Effect of lipid A incorporation on characterization of liposomal model membranes as thymus-independent type 1 or type 2 immunogens.
    Tadakuma T, Yasuda T, Tamauchi H, Saito K, Tsumita T, Kinsky SC.
    J Immunol; 1982 Jan 25; 128(1):206-10. PubMed ID: 6976372
    [Abstract] [Full Text] [Related]

  • 32. Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production.
    Moghimi SM, Hamad I, Andresen TL, Jørgensen K, Szebeni J.
    FASEB J; 2006 Dec 25; 20(14):2591-3. PubMed ID: 17065229
    [Abstract] [Full Text] [Related]

  • 33. Membrane fluidity and lipid hapten structure of liposomes affect calcium signals in antigen-specific B cells.
    Ohyama N, Hamano T, Hamakawa N, Inagaki K, Nakanishi M.
    Biochemistry; 1991 Nov 19; 30(46):11154-6. PubMed ID: 1718427
    [Abstract] [Full Text] [Related]

  • 34. Interactions of antigen-sensitized liposomes with immobilized antibody: a homogeneous solid-phase immunoliposome assay.
    Ho RJ, Huang L.
    J Immunol; 1985 Jun 19; 134(6):4035-40. PubMed ID: 3886794
    [Abstract] [Full Text] [Related]

  • 35. Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma.
    Funato K, Yoda R, Kiwada H.
    Biochim Biophys Acta; 1992 Jan 31; 1103(2):198-204. PubMed ID: 1543704
    [Abstract] [Full Text] [Related]

  • 36. Role of atheroma liposomes and malondialdehyde-modified low-density lipoproteins in complement activation.
    Sorace JM, Rollins S, Aniagolu JU, Mergner WJ, Cole K, Swartz GM, Green SJ.
    Pathobiology; 1996 Jan 31; 64(2):73-8. PubMed ID: 8888272
    [Abstract] [Full Text] [Related]

  • 37. The effect of immunoglobulin G1 structure on macrophage binding to supported planar lipid monolayers.
    Kimura K, Nakanishi M, Ueda M, Ueno J, Nariuchi H, Furukawa S, Yasuda T.
    Immunology; 1986 Oct 31; 59(2):235-8. PubMed ID: 3770803
    [Abstract] [Full Text] [Related]

  • 38. Interaction of C-reactive protein with liposomes. III. Membrane requirements for binding.
    Mold C, Rodgers CP, Richards RL, Alving CR, Gewurz H.
    J Immunol; 1981 Mar 31; 126(3):856-60. PubMed ID: 7462634
    [Abstract] [Full Text] [Related]

  • 39. Studies on the haemolytic complement of the dromedary camel (Camelus dromedarius). II. Alternate complement pathway haemolytic activity in serum.
    Olaho-Mukani W, Nyang'ao JN, Kimani JK, Omuse JK.
    Vet Immunol Immunopathol; 1995 Sep 31; 48(1-2):169-76. PubMed ID: 8533311
    [Abstract] [Full Text] [Related]

  • 40. [A study of complement fixation test by trinitrophenyl-cap-liposome: application of viral antibody test].
    Yamauchi T, Yamamoto Y, Sawayanagi Y, Hukushima M, Hikizi K, Ueda M, Masaki T.
    Rinsho Byori; 1994 Jul 31; 42(7):737-42. PubMed ID: 8065041
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.